NeuroPace, Inc. Reaffirmed earnings guidance for the year 2024. For the period, the company expects total revenue to range between $73 million and $77 million, representing growth of 12% to 18% over 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.54 USD | 0.00% | +0.61% | -36.18% |
May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.18% | 188M | |
+8.71% | 220B | |
+15.67% | 198B | |
+22.25% | 148B | |
+31.23% | 112B | |
+4.60% | 66.17B | |
+14.69% | 52.47B | |
+4.70% | 50.77B | |
-3.73% | 38.97B | |
-1.14% | 35.13B |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- NeuroPace, Inc. Reaffirms Earnings Guidance for the Year 2024